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Through the formation of concentration gradients, morphogens drive graded responses to
extracellular signals, thereby fine-tuning cell behaviors in complex tissues. Here we show that
the chemokine CXCL13 forms both soluble and immobilized gradients. Specifically, CXCL13+
follicular reticular cells form a small-world network of guidance structures, with computer
simulations and optimization analysis predicting that immobilized gradients created by this
network promote B cell trafficking. Consistent with this prediction, imaging analysis show that
CXCL13 binds to extracellular matrix components in situ, constraining its diffusion.
CXCL13 solubilization requires the protease cathepsin B that cleaves CXCL13 into a stable
product. Mice lacking cathepsin B display aberrant follicular architecture, a phenotype
associated with effective B cell homing to but not within lymph nodes. Our data thus suggest
that reticular cells of the B cell zone generate microenvironments that shape both immobi-
lized and soluble CXCL13 gradients.
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Nonhematopoietic stromal cells regulate the developmentand maintenance of niches within lymphoid tissues tosupport the retention, activation, and proliferation of
adaptive immune cells in response to antigenic stimulation1–4. In
the context of antibody-mediated immunity, B cells must migrate
to the follicle where they (i) acquire and process antigen; (ii)
present antigen to CD4+ T helper cells; and (iii) organize into a
germinal center (GC)5. Through the secretion of signaling
molecules, fibroblastic reticular cells orchestrate both trafficking
of B cells to and within different tissue subcompartments, with
dysregulation of migration leading to defective follicular
homing6,7, aberrant follicular and GC organization7,8, and GC-
derived lymphomas9.
Despite the importance of these migratory cues, the distances
and scales over which they act are unclear. Many studies suggest
that soluble factors, such as the cytokine IL-2, are spatially
regulated through a diffusion−consumption mechanism that
creates a concentration gradient capable of fine-tuning cell
behaviors through a graded exposure to ligand10. Consistent with
the source-sink scheme of gradient formation, atypical chemo-
kine receptor 4-expressing lymphatic endothelial cells (LECs)
lining the ceiling of the subscapular sinus have been implicated in
the formation of functional CCL21 chemokine gradients in the
lymph node11. Interestingly, both molecules are known to
dynamically interact with extracellular matrix (ECM) compo-
nents such as glycosaminoglycans (GAGs)12–15. Many soluble
factors have carbohydrate-binding domains, a feature that may
limit the capacity to undergo free diffusion, particularly in dense
tissues12–14,16,17.
For many molecules, the ability to bind ECM components is a
key determinant of functionality18,19. In vivo, truncation of the
highly charged C-terminus of CCL21 prevents its immobilization
to high endothelial venules (HEVs) while the mutant forms of CC
chemokines that lack GAG-binding domains fail to induce che-
motaxis into the peritoneum18,20. Mice carrying a mutated form
of CXCL12 (CXCL12gagtm) where interactions with the ECM are
impaired have disorganized GCs, as well as having fewer somatic
mutations in immunoglobulin genes21. These experimental stu-
dies are supported by mathematical analyses predicting that
gradient formation is increased when chemokines are secreted in
matrix-binding form as compared to a non-matrix-interacting
form22. This dichotomy has been explicitly studied in the context
of CCL21, where immobilized and soluble gradients promote
adhesive random migration or chemotactic steering of dendritic
cells, respectively15.
In this study we focus on the chemokine CXCL13, a small
globular protein with a theoretical average mass of 10.31 kDa that
has emerged as a key regulator of B-cell migration and lymphoid
tissue architecture, with CXCL13−/− mice displaying aberrant
follicular organization7,23,24. Similarly, mice deficient in CXCR5,
the cognate receptor for CXCL13, have defective formation of
primary follicles and GCs in the spleen, with B cells failing to
home effectively to the follicles6,7. CXCL13 bioavailability is a
dynamic function of production, diffusion, immobilization,
mobilization, and consumption25. Consequently, the precise
localization of CXCL13 within lymphoid tissues is difficult to
visualize directly.
During selective ablation of follicular reticular cells, also known
as follicular dendritic cells (FDCs), follicles remodel into dis-
organized bands of B cells that retain CXCL13-expressing stromal
cell populations3, suggesting that the cellular sources of this
molecule are heterogeneous4. The expression patterns of CXCL13
also vary temporally over the course of immunization and
infection. Expression is regulated in a positive feedback loop
involving CXCR5-mediated induction of LTα1β2 expression by B
cells which in turn contributes to maximal CXCL13 production7.
Once secreted, CXCL13 must diffuse through a dense environ-
ment comprising lymphocytes, reticular cells, vasculature, lym-
phatics, and ECM before undergoing internalization by typical
and atypical chemokine receptors or protease-mediated enzy-
matic degradation11,26,27. CXCL13 has been shown experimen-
tally to interact with heparan sulfate via two distinct binding
interfaces17. Consistent with this structural study, recent single-
molecule imaging measurements of chemokine diffusion in
ex vivo murine tissue sections and collagen matrices suggest that
chemokines may be heterogeneous in their mobility behaviors,
with CXCL13 diffusion tightly constrained in tissues28. An
additional layer of complexity is added by the heterogeneous
distribution of ECM proteins within the follicle29 and by altered
chemotactic potency of many chemokines following proteolytic
cleavage30,31. A number of proteases are known to alter chemo-
kine activity including matrix metalloproteinases, dipepti-
dylpeptidase IV (CD26), aminopeptidase N (CD13), neutrophil
granule proteases, and members of the cathepsin family30,31.
However, the role of proteolytic processing in the context of
gradient formation in vivo is poorly understood.
Given the complexity of the CXCL13 regulatory network, it is
unclear if the molecule acts in an immobilized or soluble form
and whether proteolytic processing is required to modulate
CXCL13 function in vivo. This limited understanding is exacer-
bated by a dearth of experimental techniques capable of manip-
ulating molecular gradients in situ. Our aim is to understand the
mechanisms that create CXCL13 gradients within the B-cell fol-
licle. Here, we employ a modeling and simulation approach,
mapping the reticular cell architecture of the primary follicle and
reconstructing it in silico. We then apply a combination of
machine learning and optimization approaches to systematically
generate different chemotactic gradients and assess associated B-
cell scanning rates. Using this approach, it is possible to obtain
insights where direct experimentation is intractable, generating
data with high spatial and temporal sensitivity across multiple
scales of organization.
Using a modeling and simulation approach, in combination
with imaging and biochemistry, we assess the mechanisms that
regulate CXCL13 gradient formation within lymphoid tissues.
Our integrative approach shows that within the follicle, CXCL13
can exist in a soluble or immobile form. CXCL13 solubilization is
regulated by the protease cathepsin B (Ctsb), with cleaved
CXCL13 showing altered binding kinetics and increased che-
motactic potency. Strikingly, in Ctsb-deficient mice, B-cell loca-
lization is highly variable, with an increased propensity to form
ring-like structures around the T-cell zone, suggesting a key role
for soluble CXCL13 in follicle formation. Our data thus suggest
that reticular cells of the B-cell zone generate microenvironments
that shape both immobilized and soluble CXCL13 gradients.
Results
Mapping CXCL13± stromal cell networks in the B-cell follicle.
In this study we couple experimental and modeling approaches to
identify and enumerate key entities and processes that regulate
CXCL13 bioavailability (Supplementary Fig. 1). To understand
the cellular sources of CXCL13 within the primary follicle, we
mapped the 3-dimensional (3D) organization of CXCL13+ stro-
mal cells in lymph node tissue sections from Cxcl13-Cre/Tdto-
mato R26R-EYFP (abbreviated as Cxcl13-EYFP) mice4. In
Cxcl13-EYFP mice, EYFP acts as a lineage marker, endogen-
ously expressed in cells that originate from a CXCL13-producing
precursor, while TdTomato expression (red fluorescent protein,
RFP) is confined to cells with current CXCL13 promoter activity.
In addition, we identify FDCs as cells that are also CD21/35
positive (Fig. 1a). From a follicle tissue cross-section, we mapped
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a network of 198 ± 39 nodes and 1163 ± 242 edges (n= 4 mice),
whereby we define nodes as the EYFP+RFP+ reticular cells (RCs)
and FDCs, while edges are indicated as physical connections
between neighboring nodes (Fig. 1a, Supplementary Table 1). We
subdivide CXCL13+ follicular reticular cells into two broad
categories: CXCL13+ CD21/35+ FDCs and CXCL13+ CD21/35−
reticular cells (CD21− RCs) comprising reticular cells located
underneath the subcapsular sinus (marginal reticular cells), and at
the outer follicle. Interestingly, FDCs display significantly higher
degree centralities and edge lengths than CD21− RCs, forming a
dense subnetwork within the follicle (Fig. 1b, c). Topological
analysis (as described in Supplementary Note 1) of the clustering
coefficients (Cglobal= 0.57 ± 0.02, Clocal= 0.60 ± 0.02) and the
average shortest path length (4.17 ± 0.26) through the network
has revealed a significant difference in the topological organiza-
tion of the follicle network as opposed to an equivalent random
network with the same number of nodes and edges (Clocal= 0.06
± 0.01, Cglobal= 0.06 ± 0.01 and shortest path length= 2.41 ±
0.11). These results indicate that the follicle network exhibits
small-world properties (Fig. 1d, e) reminiscent of the T-cell zone
FRC network32. These findings are further corroborated by
comparing the follicle network to an idealized small-world
network (WS), demonstrating their similarity in topological
organization and small-world network metrics σ and ω (Supple-
mentary Table 1). The small-world configuration is characterized
by an overabundance of highly connected nodes, common con-
nections mediating the short mean-path lengths. This property is
associated with rapid information transfer and is also observed in
airline routes and social networks33,34. In the context of the fol-
licle, this property is likely to promote complement-mediated
trafficking of antigen by non-cognate B cells from the subcapsular
sinus to the FDC network, and also the migration of cognate B
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Fig. 1 The topological network properties of CXCL13+ follicular stromal cells. a Mapping confocal images of lymph node follicles taken from Cxcl13-cre/
EYFP reporter mice using the Imaris image analysis software. The FDC subnetwork is highlighted in yellow and the RC subnetwork in cyan. Distributions of
degree centrality, edge length and local clustering coefficient are indicated for the FDC and RC subnetworks (b−d). e Distribution of shortest path lengths
is indicated for the global follicular network and are compared to that of an equivalent random network with the same number of nodes and edges (f). Data
represent mean ± SD for n= 4 mice. Statistical significance was determined using a two-way ANOVA with Sidak’s multiple comparison test. *p < 0.05,
**p < 0.01, ***p < 0.001. Scale bar= 50 μm. Source data are provided as a Source Data file.
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cells as they search for antigen within the follicle, and then pre-
sent it to T cells at the interfollicular border before seeding a GC
reaction5,35,36.
Simulating and optimizing CXCL13 gradients in silico. Since
the structural organization of CXCL13+ reticular networks are a
key determinant of follicle functionality, we hypothesized that
that this cellular architecture may also regulate the molecular
level patterning of CXCL13. To address this hypothesis, we use
the stromal cell topology dataset to inform an algorithmic
reconstruction of the follicular reticular cell network in silico37.
Coupled with additional imaging datasets (Supplementary Fig. 1),
we engineered a high fidelity (Supplementary Fig. 3) multiscale
representation of the primary follicle in which immune cell agents
can interact with reticular cells, creating and shaping complex
physiological CXCL13 gradients (Fig. 2a, Supplementary Note 3).
This quantitative approach facilitates simulation analysis of
CXCL13 gradient formation at very high spatiotemporal resolu-
tion but does require significant computational resources to
evaluate (detailed in Supplementary Note 2), limiting the range of
analysis techniques we can apply to understand CXCL13 gradient
formation. To address this issue, we complemented our simula-
tion analysis with an emulation-based approach (Fig. 2b, Sup-
plementary Fig. 2). In this approach a machine-learning
algorithm known as an artificial neural network (ANN) was
used to learn the emergent behaviors of the simulator, such that it
was capable of rapidly and accurately mapping between simula-
tion inputs and outputs averaged over a high number of replicate
runs (Fig. 2b, Supplementary Fig. 2).
To assess whether CXCL13 acts in principally an immobilized
or a soluble form, we focused on two potential models: Model
1 suggests that CXCL13 binds to ECM components creating short
sharp gradients proximal to the CXCL13-secreting cells, while in
model 2 where CXCL13 is largely soluble and diffuses more freely
throughout the tissue, creating a more homogeneous pattern
(Fig. 2c). To assess the veracity of each theory, a chemotactic
landscape was created for each model through tuning parameters
that control the rate of secretion, diffusion, and decay but keep
overall concentration fixed and the emergent scanning rates of in
silico B cells were quantified under each scenario. This analysis
predicted that model 1 yields higher scanning rates than model 2,
suggesting that model 1 is more likely (Fig. 2d). To further assess
the veracity of this result, we perform an optimization analysis to
determine the most effective spatial distribution of CXCL13 with
respect to antigen scanning. In this analysis we employed the
nondominated sorting genetic algorithm-II (NSGA-II)38,39 to
systematically perturb parameters relating to CXCL13 bioavail-
ability in silico and determine a Pareto front of solutions
(emergent cell migration behaviors) that represent the best trade-
off obtained between fitting experimentally determined migration
patterns (objectives 1−3, detailed in “Methods”)40 and maximiz-
ing scanning rates (objective 4, detailed in “Methods”)40. Despite
using a heuristic approach, performing this analysis on our
multiscale simulator is computationally intensive due to: (i) a
highly complex search space; (ii) the need for replicate runs to
mitigate stochastic uncertainty; and (iii) multiple, conflicting
objectives. To address this, we combined NSGA-II with our
ANN-based emulator, an approach to determine the precise
spatial distribution of CXCL13 that would not only fit our data,
but also lead to optimal B-cell scanning rates. This approach
allowed us to examine the distributions of parameter values that
give rise to our optimal solutions, such that we can mechan-
istically understand why some spatial patterns are more effective
than others. More specifically, we found that values of the
CXCL13 diffusion constant are skewed towards low values, and
decay rates skewed towards high values (Fig. 2e), consistent with
model 1. In addition, we find that our objectives are conflicting,
with increased scanning rates leading to poorer agreement
between emergent cell behaviors in silico and laboratory measures
(Fig. 2f). Our theoretical analysis predicts that immobilized
CXCL13 gradients are a key determinant of B-cell trafficking
patterns within the follicle.
CXCL13 forms immobilized gradients within the B-follicle. To
assess our theoretical prediction that CXCL13 can form immo-
bilized gradients, we quantify binding of CXCL13AF647 to tonsil
tissue sections incubated with heparinase-II, an enzyme that
cleaves both heparin and heparan sulfate or phosphate-buffered
saline (PBS) (Fig. 3a). By quantifying the fluorescent intensity for
each image, we determine a significant drop in fluorescence
intensity following heparinase-II treatment, suggesting that
CXCL13 binds heparin and/or heparan sulfate in lymphoid tissue
follicles (Fig. 3b). To assess whether heparin and heparan sulfate
constrain diffusion, we image CXCL13AF647 diffusion within
CD19+ B-cell follicles of tonsil tissue sections and quantify
mobility with super-resolution precision at ∼500Hz41 (Fig. 3c).
Consistent with simulation analysis and immunohistochemistry,
we find that CXCL13AF647 is largely immobile yielding a median
[IQR] diffusion rate of 0.19 [0.001−0.79] μm2 s−1, while treatment
with heparinase-II led to increased rates of diffusion with a sample
median [IQR] diffusion coefficient of 1.6 [0.47−3.9] μm2 s−1
(p < 0.0001) (Fig. 3c).
Our super-resolution imaging assay permitted the tracking of
single CXCL13 molecules, allowing us to characterize the
heterogeneity of CXCL13 mobility in situ. Specifically, we
identified and characterized distinct matrix bound (low-mobility)
and soluble (high-mobility) fractions (Fig. 3d). Relative to the
immobile fraction only a very small proportion of CXCL13 was
soluble, consistent with theoretical results. Disruption of the ECM
through heparinase-II treatment did lead to an increase in the
mobile fraction. Given that such a large proportion of CXCL13
was immobilized, we assessed whether we could detect an
immobile CXCL13 fraction within B-cell follicles using immu-
nohistochemistry in fixed human tonsil and lymph node sections
(Fig. 4a). The spatial distribution of CXCL13 immunoreactivity is
spatially heterogeneous and strongly colocalized with the FDC
marker CD35 (Fig. 4a). To quantify this observation, we measure
the spatial autocorrelation of CXCL13 expression in tonsil
sections and determine the distance (Duncorrelated) at which there
is no statistically significant correlation in fluorescence intensities
(Fig. 4b, c). This analysis indicates that CXCL13 expression is
significantly correlated over short distances (∼50 μm) before
becoming significantly uncorrelated with no statistically signifi-
cant difference in Duncorrelated between human tonsils and model
1, corroborating our theoretical observation that CXCL13 can
form complex immobilized gradients in the follicle (Fig. 4b, c).
These data show that CXCL13 interacts readily with ECM
components, and together with stromal-cell network architecture,
shapes complex immobilized CXCL13 gradients within the B-cell
follicle.
Cathepsin B generates soluble CXCL13 gradients. Given the
high affinity with which CXCL13 binds to the ECM, we hypo-
thesized that it may undergo proteolytic processing. In this study
we focus on the cathepsin family; most cathepsins identified in
humans are lysosomal enzymes involved in metabolic protein
turnover but many cathepsins have also been reported to cleave
chemokines30,31. In particular, we have focused our attention on
cathepsin B (Cath-B), which has been shown to regulate cytokine
expression during Leishmania major infection42, is upregulated in
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Fig. 2 Mapping CXCL13 spatial distribution through simulation analysis and multiobjective optimization. a Overview of the multiscale model platform.
In this modular system stromal cells are modeled as a graph (Module 1), chemokine diffusion is modeled as a discretized partial differential equation
(Module 2), while B cells are modeled as agents that can interact with their local environment through a set of coupled differential equations and vector-
based calculations (Module 3). b Example structure of an artificial neural network used to emulate CXCL13Sim. The network has 13 input nodes that
connect to three hidden layers, and a single output node predicting the meandering index. A distinct network is created for each simulator output. The
hyperparameters of the network were determined using k-folds cross-validation. c The in silico follicular stromal network with a chemotactic landscape
created for models 1 and 2 by the network. d Comparison of scanning rates in silico for models 1 and 2. Each parameter set was run 200 times with
significance assessed using the Vargha−Delaney A-test70. The test statistic (0.99) exceeds the threshold for a large effect size (0.71). Bar plots represent
the median value for the emergent scanning rate and the error bars represent the IQR. e Parameter distributions for diffusion and decay rates
corresponding to the Pareto optimal solutions shown in (f) with calibrated values for each parameter shown using the dotted red line. f Using a MOEA
scheme we seek to address the following four objectives: minimize the root mean squared error between emulator and simulator responses for cell speed,
meandering index and motility coefficient; and maximize scanning rates. The Pareto front of solutions represents the trade-off in performance between cell
behaviors and scanning rates, using NSGA-II (emulation pipeline described in Supplementary Fig. 1). Source data are provided as a Source Data file.
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many cancers43, and can be produced in extracellular form in
cytokine-stimulated fibroblasts taken from rheumatoid arthritis
patients44.
Incubation of CXCL13 with Cath-B yielded two cleavage
products with masses of 9.03 and 8.68 kDa, respectively (Fig. 5a).
The smaller product is stable and forms across a range of enzyme
substrate ratios in both humans and mice (Supplementary Fig. 4a)
and is detected at pH values between 4.0 and 7.2 with an optimal
turnover rate between pH 5.0 and 6.5 (Supplementary Fig. 4b).
Consistent with these data, single-molecule imaging of CXCL13
[1–72] diffusion in 15% Ficoll showed a higher mobility rate for
the Cath-B-treated form of the molecule as compared to
untreated (1.0 [0.04−3.6] μm2 s−1 and 0.61 [0.08−2.2] μm2 s−1
respectively, p < 0.001), indicating that the fluorescent tag
incorporated into the C-terminus of the molecule had been
cleaved (Supplementary Fig. 4c).
To compare the heparin-binding capacity of CXCL13 and
CXCL13[1–72], we loaded both peptides on a HiTrap heparin
column followed by elution with an increasing concentration of
NaCl. CXCL13[1–72] displays lower heparin-binding affinity and
eluted at 0.53 M NaCl (Fig. 5b, peak 2) compared to intact
CXCL13, which elutes at 0.62 M NaCl (Fig. 5b, peak 3). To assess
if GAG-binding would protect CXCL13 from being proteolysed
by Cath-B, we performed cleavage assays in the presence of
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different GAGs including hyaluronic acid, heparan sulfate, and
chondroitin sulfate. The presence of a 5- or 10-fold (w/w) excess
of these GAGs, however, does not prevent CXCL13 processing by
Cath-B (Fig. 5c). In addition, we stained tonsil sections with an
antibody against CXCL13 and quantify the total fluorescent
intensity of each image following treatment with Cath-B or PBS
(Supplementary Fig. 5). Compared to PBS treatment, incubation
with Cath-B led to a statistically significant reduction in the
intensity of CXCL13 signal. In conclusion, GAGs do not affect
Cath-B-mediated processing of CXCL13 in situ.
To assess the effect of C-terminal truncation of CXCL13 on
cellular responses, we compared CXCL13 and its cleavage
product CXCL13[1–72] for their capacity to mobilize intracellular
calcium in CXCR5-transfected Pre-B 300-19 cells. Both CXCL13
and CXCL13[1–72] induce a rapid, transient intracellular calcium
rise (Fig. 5d, e). Analysis of internalization of CXCR5 by flow
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cytometry show that CXCL13 and CXCL13[1–72] are equally
potent inducers of internalization at concentrations of 100 and
300 nM (42.6% vs. 46.6% and 69.43% vs. 71.7% internalization,
respectively) (Fig. 5f). To determine if reduced binding of
CXCL13[1–72] to heparin might also affect the chemoattractant
activities for CXCR5+ cells, we studied in vitro migration of
primary B cells expressing endogenous CXCR5 (Fig. 5g) and
CXCR5-transfected Pre-B 300-19 (Supplementary Fig. 6) cells to
CXCL13 and CXCL13[1–72]. In both assays CXCL13[1–72]
displays greater potency than full-length CXCL13; for primary B
cells CXCL13[1–72]-induced migration at concentrations
between 10 and 100 nM was significantly higher compared to
full-length CXCL13 (Fig. 5g). Consistent with the 2D migration
assays, CXCL13[1–72] induces more potent chemotaxis of
CXCR5-transfected Pre-B 300-19 cells in a three-dimensional
matrigel at lower ligand concentrations (Supplementary Fig. 6b).
To determine if Cath-B was expressed in the follicle, we
performed IHC of tonsil tissue, with signal observed throughout
the follicle, with highest expression colocalizing with CD68+ cells
and some coexpression on CD35+ stromal cells (Fig. 5h, i).
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Analysis of the Cath-B expression in the human GC reaction
indicates a higher abundance of Cath-B-positive cells in the dark
zone and CXCL13 producing stromal cells in the light zone
(Fig. 5j). This is corroborated through analysis of tonsil tissue
lysates by western blotting (Supplementary Fig. 7) and by data
demonstrating that the in vitro culture medium of monocyte-
derived macrophages is enzymatically active when assayed with
the Cath-B-specific substrate Z-Arg-Arg-AMC. A small discern-
able effect of innate stimuli (LPS) on Cath-B function was
observed, the significance of which during immune responses
remained unclear (Supplementary Fig. 7).
To assess the in vivo importance of Cath-B in lymph node
organization and function, we performed a detailed analysis of
Cath-B (Ctsb)-deficient mice. Relative to wild type, Ctsb−/−
lymph nodes are often visibly smaller (Fig. 6a), although there
is no overall statistically significant decrease in the proportion of
B cells in LNs (Fig. 6b). To determine the role of Cath-B in B-cell
follicle formation staining of LNs was performed using antibodies
specific for B-cell markers (CD19, B220), T cells (CD4), LN HEVs
(PNAd) and stromal-cell subsets (Podoplanin, CD21/35). Strik-
ingly, we found the morphology of follicles in Ctsb−/− lymph
nodes is highly variable relative to WT. In many instances, we
observed that follicles are not always discrete, but rather form a
thin rim of B cells continued along the SCS and in many instances
we observe a ring-like structure around the central T-cell zone
(identified with immunoreactivity to CD4) (Fig. 6c).
This phenotype is suggestive of aberrant B-cell homing and
follicle formation, possibly through defects in HEV formation or
function. However, we could find no statistically significant
difference in total B-cell numbers (Supplementary Fig. 11) and
using immunohistochemistry (Meca-79) we did not observe
defects in the HEV network (Fig. 6d). Additionally, to determine
if B-cell homing is affected in Ctsb-deficient mice, CFSE-labeled
CD45.1+ B cells were transferred into either wild-type or Ctsb−/−
recipients. No difference is found in B-cell homing into the LNs
(Fig. 6e–g). In addition, confocal microscopy of LN sections
shows that while CFSE+ cells clearly overlap with B220+ areas of
WT animals, CFSE+ cells are much more disperse and are found
more frequently in B220 negative zones in Ctsb−/− mice. To
corroborate these findings, we have performed RT-qPCR on
whole LNs looking at a panel of genes relating to glycan synthesis
and the formation of PNAd+ HEV scaffolds (Glycam1, Podxl,
Cd34, Madcam1, FuctIV, FuctVII), cellular adhesion (Icam1,
Vcam1, Pecam1) and chemokines and their cognate receptors
(Cxcl13, Ccl19, Cxcr5, Ccr7). With the exception of Podxl, we find
no statistically significant difference in deltaCT values for each
gene when comparing WT and Ctsb−/− mice (Fig. 6h and
Supplementary Fig. 8). A small but nonsignificant decrease in
CXCL13 and CXCR5 was observed likely reflecting a failure in
FDC network formation (Fig. 6g). These datasets suggest that
CXCL13 can be solubilized by Cath-B, and that soluble CXCL13
gradients are essential for the formation of primary follicles
within the LN. Taken in concert our data suggest that CXCL13
can exist in both immobilized and soluble forms, with availability
fine-tuned by the reticular-cell microenvironment, and by the
enzyme Cath-B.
Discussion
Soluble factors are an essential means of communication between
cells and their environment. In the context of the immune system,
this cross-talk ensures that each B cell receives the appropriate
signal at the appropriate time5,45. However, there is currently a
lack of a well-accepted model to describe the spatial distribution
of soluble factors in situ25. The data presented in this study
highlights the importance of the tissue microenvironment in
shaping gradients and raises the question of whether assuming
free diffusion can provide sufficiently accurate theoretical models
capable of generating novel predictions.
Using a modeling and simulation approach, we show that there
is an underlying regulation to the spatial organization of CXCL13
at the cellular level, identifying a small-world network topology
with regions of high connectivity and long-range connections
between these cliques. These guidance structures are likely to
promote trafficking of cognate B cells within the different niches
of the B-cell microenvironment and the CR2-mediated delivery of
large antigen from the subcapsular sinus to the B-cell zone reti-
cular cell network by non-cognate B cells. Our data thus provide a
unique insight into how the primary follicle is structurally orga-
nized to promote B-cell homeostasis and activation. We posit that
the distinct topological properties of the reticular cell network
with dense connectivity between cells are likely to create a
labyrinth of single-cell niches, within which B cells scan for
antigen. In future studies it would be of interest to assess whether
the small-world properties of stromal cells in the primary follicle
are maintained in the secondary follicle with a formed GC.
The implications of this cellular architecture also manifest at
the molecular scale. By utilizing modeling and simulations in
conjunction with imaging approaches, we propose a model
whereby CXCL13 is largely immobile, with diffusion constrained
by the localized tissue microenvironment. While our results
indicate that heparin and heparan sulfate are important factors
regulating the spatial distribution of CXCL13 it would also be of
interest to know if other ECM components found in the follicle
also contribute to CXCL13 immobilization. Importantly, our data
suggest that immobilized CXCL13 is likely to form complex
landscapes within tissues—a conceptual change in our
Fig. 5 Cathepsin B-mediated processing of CXCL13. a 4 μM CXCL13 was incubated with 72 nM Cath-B for the indicated times at 37 °C. The cleavage
products were separated by SDS-PAGE and stained with Coomassie blue. b C-terminal truncation of CXCL13 by Cath-B leads to decreased heparin binding.
CXCL13 was incubated for 3 h with Cath-B, the reaction stopped, and the sample supplemented with intact CXCL13 and subsequently loaded on a
HitrapTM heparin column. Proteins were eluted with a NaCl gradient of 0−1.0M and absorbance measured at 280 nm. The three peaks were allocated as
Cath-B (1), CXCL13[1–72] (2) and CXCL13 (3). c Processing of CXCL13 by Cath-B at pH 6.8 was unaffected by the presence of 5- or 10-fold (w/w) excess
heparin sulfate, hyaluronic acid or chondroitin sulfate. d Representative [Ca2+]i -dependent fluorescence changes in fura-2 loaded CXCR5-transfected Pre-
B 300-19 cells induced by 30 nM CXCL13 or CXCL13[1–72]. e Dose response of calcium mobilization elicited by CXCL13 and CXCL13[1–72]. Relative units
(mean ± SD) were calculated as described in “Methods”. f CXCR5 surface expression after incubation of CXCR5-transfected Pre-B 300-19 cells with
CXCL13 and CXCL13[1–72]. CXCR5 expression levels were quantified by flow cytometry analysis. Data (mean ± SD) from at least four independent
experiments show the percentage of surface CXCR5 compared to control. g Primary human B-cell migration in response to intact and truncated CXCL13
was evaluated using 5 μm pore size Transwell filters. Data represent the percentage of migrated cells relative to the number of cells added to the Transwell
filters. Values (mean ± SD) represent at least three independent experiments. For fig. 5g statistically significant differences (determined using a Student’s
t test) are indicated, *p < 0.05 and **p < 0.01. h Colocalization of Cath-B (red) and CD68 (green) signal in tonsil follicles. h Colocalization of Cath-B and
CD68 staining in the B-follicle through immunohistochemistry analysis. i Analysis of Cath-B (Red), CD4+ T cells (brown) and CXCL13 in the B-cell follicle
and germinal center reaction dark (subpanels i and iii) and light (subpanels ii and iv) zones. Source data are provided as a Source Data file.
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understanding of the form that gradients may take in vivo.
Results from our multiobjective optimization emulation experi-
ments suggest that this spatial profile is functionally important,
promoting higher rates of scanning than homogeneous land-
scapes. These data are consistent with previous studies high-
lighting the importance of ECM components in modulating
immune cell recruitment15,18,21.
Interpretation of immobilized gradients may require proteo-
lytic processing by Cath-B, yielding a truncated molecule capable
of binding and signaling through CXCR5 but displaying reduced
affinity for the ECM. Importantly, low concentrations of CXCL13
[1–72] were more potent then intact CXCL13 in attracting
CXCR5-transfected Pre-B cells or primary B cells. Until recently,
Cath-B in immune cells was regarded as a lysosomal enzyme
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responsible for protein degradation, although cell membrane
bound Cath-B has been shown to be functional in immune cells
and can function across a range of pH values46,47. Our findings
suggest extracellular occurrence and active secretion from both
macrophages and reticular cells. Given that Cath-B activity is
most potent at low pH values, and inflammation can lead to a
decrease in tissue pH, it was interesting to note the increased
secretion of Cath-B in the presence of LPS. However, it is unclear
if this is an active release mechanism that occurs in vivo. It is
possible that the initial influx of antigen triggers increased
availability of CXCL13 at the subcapsular sinus, where antigen-
presenting macrophages can then recruit both cognate B cells and
non-cognate B cells to facilitate GC seeding and antigen deposi-
tion on the B-cell zone reticular cell network. Strikingly, follicular
architecture in Ctsb-deficient mice bears a strong resemblance to
the phenotype observed in lymphoid tissues of CXCL13-deficient
mice7, and in the spleens of CXCR5-deficient mice6. This is
consistent with a model where soluble CXCL13 drives chemo-
tactic homing behaviors while immobilized CXCL13 promotes
haptokinetic scanning within the follicle, as has been demon-
strated for CCL2115. In future studies it would be interesting to
assess the validity of this model and to assess whether perturbing
Cath-B-mediated regulation of CXCL13 in vivo can alter the
onset and efficacy of affinity maturation, and whether other
enzymes are involved in CXCL13 processing.
Engineering approaches often draw inspiration from natural
systems to solve complex design problems; however, they can
reciprocally influence our understanding of the immune system,
providing a quantitative framework from which to understand
the spatial distribution of morphogens. Using an ensemble of
different techniques, we were able to consolidate several disparate
datasets and through simulation-based experimentation have
generated insights that informed subsequent experimental work.
Specifically, we have highlighted the use of data-driven machine
learning and evolutionary computational approaches to expedite
the translation of simulator-derived insights into a better
understanding of the design, organization, dynamics, and func-
tion of complex biological systems.
In conclusion, our data suggest that CXCL13 can exist in both
immobilized and soluble forms, with the precise mode of avail-
ability dependent on enzymatic processing by Cathepsin B. This
provides a significant update in our conceptual understanding of
how homeostatic chemotactic gradients arise and form functional
gradients in complex tissues.
Methods
Enzymatic treatment of tonsil sections. Frozen lymph node or tonsil sections on
polylysine slides were incubated at room temperature for 30 min. A circle was
drawn around each section using a wax ImmEdge pen (Vector Laboratories), the
sections were then hydrated with PBS for 5 min and incubated with 150 nM
recombinant Cath-B (Sigma-Aldrich) for 3 h at 37 °C or with 10 U heparinase II
(Sigma-Aldrich) for 1 h at 17 °C. Slides were washed in PBS and then processed for
immunohistochemistry (as described below) with no fixative. All samples were
ethically approved and informed consent was obtained from all participants.
Tonsils were collected under NRES REC 12/NE/0360-approved study (IRAS:
114771) to M.C.C. Hepatic lymph nodes were collected during multiorgan dona-
tion procedures, after approval by the Medical Ethical committee of the Erasmus
MC (MEC-2014-060) by WGP.
Immunohistochemistry and immunofluorescence. Frozen lymph node or tonsil
sections on polylysine slides were incubated at room temperature for 30 min, fixed
in acetone or 4% paraformaldehyde (PFA) and then washed in PBS for 15 min in
total with changes of PBS every 5 min. Sections were incubated in a blocking buffer
of PBS and 5% serum (the serum of the host secondary antibody was raised in) at
room temperature for 1 h at room temperature. After blocking, sections were
incubated in the primary antibody mix, made up in blocking buffer for 1 h at RT.
The slides were then washed, and secondary antibody incubation was performed (if
necessary). For experiments where exogenous CXCL13AF647 was used to measure
binding to tissue, incubation of unfixed tissue sections with 500 nM CXCL13AF647
for 1 h at RT instead of the secondary antibody-staining step. Samples were washed
for 5 min in PBS. A drop of Prolong gold (Invitrogen) was added to each section,
and then a No. 1.5 glass coverslip (Fisher) mounted on top. The slides were
incubated overnight at 4 °C, the next day slides were sealed using nail varnish and
stored at 4 °C. Immunofluorescent-stained sections were imaged using the Zeiss
LSM 880 confocal microscope. Samples were excited with 405, 488, 561, and 633
nm lasers. Image acquisition was performed using the ×63 oil objective. Tile scans
and Z stacks were performed to image large tissue sections at high resolution. For
imaging of chemokine gradients, we used the Airyscan module to increase spatial
resolution beyond the diffraction limit of light. A list of commercial antibodies used
in this study are available in Supplementary Table 2.
For immunohistochemistry on human tonsil sections, specimens were fixed in
10% buffered formalin, embedded in paraffin and cut into 4-μm cross-sections for
immunostaining. Deparaffinized and rehydrated sections were boiled at 95 °C for
30 min in target retrieval solution (S1699 DAKO) and then treated with peroxidase
blocking reagent (S2001, DAKO) when needed, and protein block serum-free
(X0909, DAKO). Sections were incubated overnight at room temperature with
anti-CD3 at 5 μg/ml, anti-Cath-B at 0.12 μg/ml and anti-CXCL13 at 1 μg/ml. Next
biotinylated anti-mouse IgG, anti-rabbit IgG, or anti-goat IgG were used at 2 μg/ml
and applied for 30 min at room temperature. Slides were washed and incubated
with StreptABComplex (K0377, K0391, DAKO). Double-staining for CD3 and
Cath-B was performed in two steps; slides were blocked with 3 μg/ml rabbit IgG
(X0936, DAKO) after incubation with anti-CD3. For CXCL13 single staining in
immunohistochemistry, after anti-CXCL13 antibody, sections were incubated with
MACH1 with primary antibodies, the sections were incubated with corresponding
secondary antibodies according to the manufacturer’s instructions. Sections were
developed with either DAB or New Fuchsin and nuclei counterstained with
hematoxylin. For immunofluorescence stainings, after incubation with primary
antibodies, the sections were incubated with corresponding secondary antibodies
from Alexa for 30 min and then nuclei counterstained with DAPI.
Mouse lymph node frozen sections (8 μm) from Ctsb−/− and controls were
hydrated and washed using PBS; each wash step was 5 min, repeated three times.
Sections were incubated in blocking buffer (PBS 5% goat serum) at room
temperature for 5 min. Following blocking sections were incubated in a primary
antibody-staining mix, made up in blocking buffer, for 1 h at room temperature.
Slides were washed, then incubated in secondary antibody-staining mix, made up
in blocking buffer, for 1 h at room temperature. Following a final wash ProLong
Gold (Invitrogen) was added to each section, then a No. 1.5 glass coverslip
mounted, slides were incubated overnight at 4 °C and sealed with nail varnish. The
antibodies used in staining mixes were: MECA-79 Alexa488 (Nanotools (Custom
Product), 1 in 200 dilution); PDPN Alexa 594 (Biolegend (8.1.1) (Cat. 127414);
B220 Alexa488 (Biolegend (RA-6B2) (Cat. 103225), 1 in 200 dilution); CD4
Alexa647 (Biolegend (RM4-5) (Cat. 100516), 1 in 200 dilution); CD21/35 Alexa647
(Biolegend (7E9) (Cat. 123424) 1 in 200 dilution); and CD19 Alexa647 (Biolegend
(6D5) (Cat. 11512), 1 in 200 dilution). All experiments involving mice conformed
to the ethical principles and guidelines approved by the University of York
Fig. 6 Cathepsin B-deficient mice have abnormal follicle architecture. a Analysis of lymph node presence and morphology from WT and Ctsb−/− lymph
nodes. b Percentage of B cells, CD4+ and CD8+ T cells in WT and Ctsb-deficient LNs determined using flow cytometry, with significance assessed using a
Student’s t test. c Staining of WT and Ctsb−/− LNs with anti-B220 (B cells), anti-Podoplanin (Stroma), anti-CD4 (T cells) and anti-CD21/35 (follicular
dendritic cells). d Staining of WT and Ctsb−/− LNs for CD19 (B cells) and Meca-79 (PNAd+ HEVs). e Entry of CFSE transferred WT B cells into the LN
parenchyma of either WT or Ctsb−/− recipient mice was assessed by confocal microscopy. f Ratio of LN entry of KO:WT B cells into either WT or Ctsb−/−
recipients. To determine the relative efficiency of WT vs Ctsb−/− B cells to enter into WT or Ctsb−/− recipients, equal numbers of CSFE (ThermoFisher)-
labeled KO cells and CMTMR (ThermoFisher)-labeled WT cells were transferred into corresponding recipient mice. The ratio of transferred B (B220+)
cells KO:WT was calculated by taking into account the relative efficiency of CFSE and CMTMR labeled survival post transfer by calculating the ratio of WT
CSFE:WT CMTMR transferred cells. g Quantification of migrated CSFE-positive B cells by flow cytometry. h Analysis of Cxcl13 and Cxcr5 mRNA expression
from total LN fromWT and Ctsb-deficient mice using RT-qPCR. For panels (f−h), significance was assessed using a Student’s t test with p values provided
for each comparison. Source data are provided as a Source Data file.
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Institutional and Animal Care Use Committee in accordance with the European
Union regulations and performed under a United Kingdom Home Office License.
Reticular cell topology. Topological analysis was performed using the metho-
dology as previously described48. 3D images (approx. 450 × 450 × 35 μm) of lymph
nodes from Cxcl13-EYFP mice were obtained by laser scanning confocal micro-
scopy. Experiments were performed in accordance with federal and cantonal
guidelines (Tierschutzgesetz) under permission numbers SG10/16, SG07/16 and
SG05/15 following review and approval by the Cantonal Veterinary Office (St.
Gallen, Switzerland). The topological mapping of follicular stromal cell network
structure was created as an undirected unweighted graph by defining nodes as the
EYFP+RFP+ follicular stromal cells and edges as physical connections between
neighboring nodes. The network edges in 3D Z-stack images were annotated using
the Measuring Tool in Imaris (Bitplane) such that a straight line is demarcated
between adjacent stromal cells that are connected by a cellular protrusion or
smaller branching process with no other cell body directly blocking this connec-
tion. Analysis of key topological parameters (described in Supplementary Table 1)
was performed using the iGraph package in R. These parameters enable the
assessment whether the network has small-world properties as has been reported
for T-cell zone FRC networks in lymph nodes32. Although many additional
topological and structural metrics exist, the metrics proposed in this study are
sufficient to perform a basic characterization of the follicle network, while also
providing quantitative data to inform the algorithmic reconstruction of an in silico
stromal network model.
Quantifying the spatial autocorrelation of fluorescence. To quantify the spatial
autocorrelation of fluorescence intensity, 2D confocal images were acquired on a
Zeiss LSM 880 confocal microscope with the same laser settings and post pro-
cessing for each sample. Processed .png files were then analyzed in R using custom
scripts. Briefly, this analysis involved discretizing the image into 14.44 µm2 bins
and calculating the spatial correlogram using the correlog function from the ncf
package. Spatial autocorrelation is quantified using Moran’s I statistic with sig-
nificance assessed through permutation testing49,50.
Super-resolution imaging. Frozen tonsils sections on polylysine slides were
incubated at room temperature for 30 min. Samples were hydrated in PBS for 5
min, then left to dry and circles were drawn around each section with a wax
ImmEdge pen (Vector Laboratories). Sections were incubated in a blocking buffer
of PBS+ 5% goat serum (Sigma) at room temperature for 1 h. After blocking,
sections were incubated in primary antibody mix (anti-B220 FITC, eBioscience)
made up in 1:200 blocking buffer for 1 h at room temperature. Samples were
washed with PBS for 3 × 5 min and 30 nM of CXCL13-AF-647 were added to the
slides. Slides were left to incubate overnight at 4 °C after which slides were washed
for 30 s in PBS and a No. 1.5 glass coverslip (Fisher) mounted on top.
Bespoke fluorescence microscopy was performed on an inverted microscope
(Nikon Eclipse Ti-S) with a ×100 NA 1.49 Nikon oil immersion lens and
illumination from a supercontinuum laser (Fianium SC-400-6, Fianium Ltd.),
controlled with an acousto-optical tunable filter to produce a narrow-field
excitation light centered on 619 nm51,52. The use of narrow-field imaging permits
fluorescent excitation at distance of a few hundred nanometers above the coverslip
thus mitigating some of the boundary effects that may be encountered using total
internal fluorescence microscopy where only a thin section directly above the
coverslip is excited53. A 633-nm dichroic mirror and 647-nm long-pass emission
filter were used to filter the appropriate wavelengths of light emitted from the
fluorescence images. Images were recorded on an emCCD camera (860 iXon+,
Andor Technology Ltd) cooled to −80 °C. 128 × 128 pixel images were acquired for
1000 frames with 1.98-ms exposure times. The camera was in frame transfer mode
with the resulting frame rate being 513 Hz. The electron-multiplier gain was set to
300. The kinetic series were saved as TIFF format files (.tiff). When imaging in
tissue, sections were stained with an anti-B220 (1 in 200 dilution) antibody
conjugated to FITC. Samples were imaged at low (1.2 µm/pixel) magnification with
green illumination (470 nm) to determine the location of the B-cell follicles, before
switching to high (120 nm/pixel) magnification and red illumination to image
chemokines in these areas.
The analysis of the kinetic series was done in bespoke Matlab software, namely
ADEMS code52, which enabled objective single-molecule detection and tracking to
within 40-nm spatial precision, utilizing a combination of iterative Gaussian
masking and local background subtraction to calculate sub-pixel precise estimates
for the intensity centroid of each candidate fluorescent dye in the image with edge-
preserving filtration of intensity data and Fourier spectral analysis to confirm
detection of single dye molecules54–57.The code was first performed on simulated
kinetic series that mimicked the signal and noise landscape of real image data. The
parameter settings such as values for the signal-to-noise ratio and the Gaussian
mask size of ADEMS code were set so that the code accurately identified the signals
in the simulated data. These parameters were then used in the code for the
identification of single fluorescent signals in real data. From these fluorescent spots
ADEMS code then produced trajectories of fluorophores that last five or more
consecutive frames to allow the calculation of microscopic diffusion coefficients as
the gradient of a linear fit to the first four positions in each track58,59. These
coefficients were plotted in histograms with integer bin sizes for easy comparison
between the experiment and the control groups.
Emulator development. As an agent-based model, a number of high-level prop-
erties emerge from the simulator due to aggregated interactions between agents and
their environment60,61. To learn the complex relationship between parameter
inputs and emergent agent behaviors, we employ a supervised machine-learning
approach. Supervised learning involves generating a dataset of inputs (x) and
outputs (y) and then teaching an algorithm to approximate a mapping function
between the two. With a sufficiently accurate mapping function, it is then possible
to predict y for a set of unobserved values of x.
The training dataset for emulator development was obtained using Latin
hypercube sampling62, with 3000 parameter sets. Each set was executed 100 times
to mitigate aleatory uncertainty, and median responses calculated to summarize
simulator performance under those conditions.
To map the complex relationship between parameter inputs and the emergent
properties of the model, we train an ANN using the SPARTAN63 package in R.
ANNs are a technique inspired by the neuronal circuits in the brain, with
computations structured in terms of an interconnected group of artificial neurons
organized in layers. In this scheme parameter inputs are passed into the network
and iteratively processed by a number of hidden layers. Within each hidden layer
the sum of products of inputs and their corresponding weights are passed through
a sigmoidal activation function that is fed as inputs into the next layer. This process
is repeated until the output layer is reached and we have a prediction for the output
values. During the learning phase, the weighting of connections between neurons is
adjusted in such a way that the network can convert a set of inputs (simulation
parameters) into a set of desired outputs (simulation responses)64.
A key technical consideration when developing neural networks is how to
evaluate predictive power. Testing predictive performance on the training data is
not useful as it can lead to overfitting, whereby the network is poor at predicting
previously unobserved data. To solve this problem, a proportion of the dataset is
omitted from the training dataset and used to validate algorithm performance. To
evaluate the predictive power of the emulator, we partition the LHC dataset into
training (75%), testing (15%), and validation (10%) datasets. Partitioning the data
incurs a cost however, as we reduce the number of samples used for training the
model. In addition, the data used to train the model, even if not used in the
evaluation process, can have a significant impact on predictive performance. To
address these issues, we perform a procedure known as k-folds cross-validation. In
this scheme the data are partitioned into k-folds and the algorithm learns the
mapping between inputs and outputs using k− 1 folds as training data with
validation performed on the remaining part of the data. This process is repeated
until each fold is used as the test set with overall performance taking as the average
for each fold. To develop our ANN, we generate multiple neural network structures
with different number of hidden layers and nodes within each layer (so-called
hyperparameters) but fixed input and output layers (one node for each distinct
input and output respectively). The accuracy of each putative network was
quantified using the root mean squared error between the predicted cell behavior
responses and those obtained by the simulator. Using this approach an ANN was
developed for each simulation output metric with network structures presented in
Supplementary Fig. 9.
Multiobjective optimization. Multiobjective optimization analysis was performed
using the nondominated sorting genetic algorithm II (NSGA-II), a multiobjective
genetic algorithm39. This analysis was performed in R using the package mco v15.0.
The four objectives to be optimized by the algorithm were to: minimize the root
mean squared error between emulator and simulator responses for cell speed,
meandering index and motility coefficient, and maximize scanning rates.
Preparation of recombinant Cxcl13. Preparation of recombinant CXCL13, full-
length and 1–72 form was prepared as described previously65. CXCL13 labeled
with the fluorescent tag AF647 was purchased from Almac.
CXCL13-processing by Cath-B. Synthetic human or mouse CXCL1366 was
incubated with purified human liver Cath-B (Athens) (for mice CXCL13 was
incubated with recombinant Cath-B purchased from R&D Systems) at 37 °C in
Dulbecco’s PBS (DPBS, Invitrogen) pH 6.8 containing 4 mM Ethylenediaminete-
traacetic acid (EDTA) and 2 mM L-cysteine. The reaction was stopped by boiling
the samples at 95 °C for 5 min. The chemokine cleavage products were separated by
Tris-Tricine SDS-PAGE and stained with Coomassie blue. Enzymes were activated
as per the manufacturer’s instructions.
Interaction of CXCL13 with glycosaminoglycans. CXCL13 and CXCL13[1–72]
binding to heparin was characterized by loading respective chemokine samples on
a 1 ml HitrapTM heparin column (GE Healthcare). Bound CXCL13 and CXCL13
[1–72] were eluted using a linear gradient of 0−1.0 M NaCl in 10 mM potassium
phosphate, pH 7.5 over 30 min at a flow rate of 1 ml/min and monitored by
absorbance at 280 nm on a DuoFlow system (Bio-Rad). The impact of soluble
GAGs on CXCL13 processing by Cath-B was determined by performing CXCL13
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cleavage experiments in the presence of hyaluronic acid, heparan sulfate or
chondroitin sulfate (Sigma).
Intracellular calcium mobilization. CXCL13-induced changes in cytosolic-free
Ca2+-concentration [Ca2+]i were measured in CXCR5-transfected mouse Pre-B
300-19 cells24. Cells were loaded with 0.2 nmol of fura 2-AM per 106 cells for 20
min at 37 °C in a buffer containing 136 mM NaCl, 4.8 mM KCl, 1 mM CaCl2, 1 mg/
ml glucose and 20 mM Hepes, pH 7.4 (MSB). After centrifugation, fura-2-loaded
cells were resuspended in MSB, stimulated at 37 °C with the indicated con-
centrations of intact or truncated CXCL13, and the [Ca2+]i-related fluorescence
changes were recorded as previously described67. Relative units are calculated as
the ratio of the fluorescence signal after chemokine stimulation and a calibration
signal.
CXCR5 internalization. 3 × 105 CXCR5-transfected Pre-B 300-19 cells were
washed with DPBS and incubated for 45 min at 37 or 4 °C (control) in 50 µl DPBS
containing 2% PPL (human albumin, CSL Behring) and the indicated concentra-
tions of intact or truncated CXCL13. Cells were then washed with ice-cold DPBS
supplemented with 1% BSA (fraction V, Applichem) and 0.04% sodium azide and
blocked with 3 mg/ml Vivaglobulin (CSL Behring) for 12 min at 4 °C before
incubation with anti-human CXCR5 antibody (1:40) or isotype control (1:40).
Surface receptor expression was evaluated by flow cytometry.
Cell migration. Two-dimensional chemotaxis assays with human B cells and
CXCR5-transfected Pre-B 300-19 cells were carried out in 5-µm pore size Trans-
well plates (Costar). Cells were washed and resuspended at 5 × 106 cells/ml in
RPMI containing 10% FBS (Invitrogen), L-glutamate, sodium pyruvate and 2-
mercaptoethanol. Chemokines were diluted in the same buffer and added to the
wells. Filter inserts were then placed in the wells and the assay was started by
adding 100 µl of cell suspension into the filter inserts. After 2 h at 37 °C and 5%
CO2, the filter inserts were removed, and the migrated cells counted by flow
cytometry (FACSCalibur Becton Dickinson) for 30 s using a high flow preset.
Assays were carried out in duplicates and tests from different days were standar-
dized by measuring PKH26 reference microbeads (Sigma) under the same condi-
tions. Cell migration in a 3D setup was assessed as described previously68,69.
Briefly, 5 × 104 CXCR5-transfected pre-B 300-19 cells in 100 µl RPMI 1640 med-
ium supplemented with 10% fetal calf serum and 0.1% β-mercaptoethanol were
pre-mixed at 4 °C with growth-factor reduced Matrigel (Corning, BD Biosciences
#356231) to a final Matrigel concentration of 300 µg/ml and seeded to the upper
well of a 24-well TranswellTM System and polycarbonate filters with a pore size of
5 µm (Corning Costar). Matrix was allowed to polymerize for 2 h at 37 °C/5% CO2.
Cells were subsequently allowed to migrate through the Matrix for 3.5 h towards
the lower well containing graded concentrations of the chemokines. The numbers
of input and migrated cells were determined by flow cytometry (LSRII, BD
Biosciences).
Quantifying lymph node cellularity. Accucheck counting (Invitrogen) beads were
used to calculate total cellularity of murine popliteal lymph nodes. Following
antibody staining, pellets were resuspended in 100 μl FACS wash. One hundred
microliters of counting beads were mixed for 1 min to ensure they were evenly
resuspended before running on the flow cytometer. To ensure accuracy the beads
are made up of two types of beads that differ in their fluorescent intensity; for
accurate readings, the two populations should be present at approximately 50:50
ratio. To calculate the absolute cell number, the following calculation was then
made:
Number of cells per μl ¼ Number of events ðbeadsÞ
Number of events
´Number of beads per μl;
where the number of beads per μl was provided by the supplier and varied with
each batch. The total cellularity of the lymph node could be calculated using the
values of cells per μl and final volume of FACS wash that contained the cells.
Real-time quantitative PCR. RNA was extracted from whole LNs using RLT buffer
(Qiagen), the lysates were stored at −20 °C overnight. RNA extraction was performed
using an RNeasy mini kit (Qiagen). Quantity and quality of RNA was measured using
a NanoDrop spectrophotometer. Samples were stored at −80 °C. cDNA synthesis was
performed using the high-capacity cDNA Reverse Transcription Kit (Applied Bio-
systems) and a thermo cycler PCR machine. cDNA samples were stored at −20 °C.
The following Taqman probes (ThermoFisher cat. 4331182) were utilized: CCL19
(Mm00839966_g1); CXCL13 (Mm04214185_s1); GlyCAM-1 (Mm00801716_m1);
Podxl (Mm00449829_m1); CD34 (Mm00519283_m1); MADCAM (Mm00522088_
m1); FucT IV (Mm00487448_s1); FucT VII (Mm04242850_m1); VCAM
(Mm01320970_m1); PECAM (Mm01242576_m1); ICAM (Mm00516023); CXCR5
(Mm00432086_m1); CCR7 (Mm99999130_s1).
B-cell in vivo homing assays. B220+ B cells were isolated from CD45.1 congenic
mice, and stained with anti-B220, sorted on a S3 Bio-Rad cell sorter and labeled
with CFSE for 10 min in serum-free medium. Labeled cells were washed in
complete medium prior to resuspension in PBS, 107 B220+ CFSE labeled were
transferred intravenous into either Ctsb−/− or wild-type recipients. Twenty-four
hours post transfer, LNs were isolated and 8 mm frozen sections cut. Sections were
counterstained with anti-B220 Alexa647 (Biolegend) and imaged on a Zeiss 810
confocal microscope. Experiments were performed in accordance with federal and
cantonal guidelines (Tierschutzgesetz) under permission numbers SG10/16, SG07/
16, and SG05/15 following review and approval by the Cantonal Veterinary Office
(St. Gallen, Switzerland). To determine the relative efficiency of WT vs. Ctsb−/− B
cells to enter into WT or Ctsb−/− recipient mice, equal numbers of CSFE (Ther-
moFisher)-labeled KO cells and CMTMR (ThermoFisher)-labeled WT cells were
transferred into the corresponding recipient mice. The absolute number of B cells
was determined by multiplying absolute cell counts from individual matched
inguinal LNs using CASY with flow cytometry analysis of isolate lymphocytes with
CD19-APC (Biolegend) and CD3eBrilliantViolet (Biolegend) on a FortessaX20
(BD). The ratio of transferred B (B220+) cells KO:WT was calculated in both LN
and spleen of the different recipient mice taking into account the relative efficiency
of CFSE and CMTMR labeled survival post transfer by calculating the ratio of WT
CSFE:WT CMTMR transferred cells (Cell number × % B cells of CFSE+ or
CMTMR+ populations). The gating strategy for flow cytometry analysis is shown
in Supplementary Fig. 12. This methodology removed the effect of CMTMR
nonspecifically affecting the efficiency of dye labeled lymphocyte survival post
transfer.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Source Data are provided in Zip folder. All raw datasets (1.5 GB zip file) that support the
findings of this study are available from the corresponding author upon reasonable
request.
Code availability
A brief overview of the simulator platform is presented in Supplementary Note 3. A full
description of model simulator design, development and validation, as well as associated
source code, is available from https://www.kennedy.ox.ac.uk/technologies/resources/
cxcl13sim.
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